While a relatively inconsistent trend of MCT1 expression levels was observed with several mouse disease models, a marked reduction in MCT1 transcript levels were detected in human idiopathic and ischemic cardiomyopathies, perhaps suggesting a link in ICM disease progression (Fig. 9b). This evidence concerns the gene SLC16A1 and ischemic cardiomyopathy.